NEW ENTERPRISE ASSOCIATES 13 LP Insider Trading $PHAS PhaseBio Pharmaceuticals Inc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for NEW ENTERPRISE ASSOCIATES 13 LP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of NEW ENTERPRISE ASSOCIATES 13 LP. NEW ENTERPRISE ASSOCIATES 13 LP is 10% Owner in PhaseBio Pharmaceuticals Inc ($PHAS) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in Workday, Inc. ($WDAY) and 10% Owner in AEROHIVE NETWORKS, INC ($HIVE) and 10% Owner in BOX INC ($BOX) and 10% Owner in Millennial Media Inc. ($MM) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Cloudflare, Inc. ($NET) and 10% Owner in Omthera Pharmaceuticals, Inc. ($OMTH) and Director in Omthera Pharmaceuticals, Inc. ($OMTH) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Sprout Social, Inc. ($SPT) and 10% Owner in CVENT INC ($CVT) and 10% Owner in Dermira, Inc. ($DERM) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM).

NEW ENTERPRISE ASSOCIATES 13 LP in PhaseBio Pharmaceuticals Inc

Trading Symbol: PHAS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NEW ENTERPRISE ASSOCIATES 13 LP: 10% Owner
Holdings: 4,841,634 shares
Latest Transaction: Oct 24 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of NEW ENTERPRISE ASSOCIATES 13 LP in PhaseBio Pharmaceuticals Inc

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, HIVE, BOX, CRCM, NET, CLVS, CVT, DERM, EPZM, GLYC, MM, OMTH, PHAS, RARX, RYTM, ROKA, SPT, TSRO, WDAY

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseC0.001,124,30100
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseC0.00437,70600
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseS0.004,3490437,706
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseX0.00181,1900442,055
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseX0.12181,19021,7430
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseC0.003,279,62700
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseS0.001,17703,279,627
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseX0.0049,03003,280,804
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseX0.1249,0305,8840
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerBuyP5.001,800,0009,000,0006,641,6344.8 M to 6.6 M (+37.18 %)
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerBuyC0.004,841,63404,841,6340 to 4.8 M

Page:   1